Gotowa bibliografia na temat „Interleukin-6”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Interleukin-6”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Interleukin-6"

1

&NA;. "Interleukin-3/interleukin-6." Reactions Weekly &NA;, no. 550 (1995): 11. http://dx.doi.org/10.2165/00128415-199505500-00035.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

&NA;. "Interleukin-6." Reactions Weekly &NA;, no. 570 (1995): 9. http://dx.doi.org/10.2165/00128415-199505700-00023.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Lotz, Martin. "Interleukin-6." Cancer Investigation 11, no. 6 (1993): 732–42. http://dx.doi.org/10.3109/07357909309046948.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

&NA;. "Interleukin 6." Inpharma Weekly &NA;, no. 877 (1993): 2. http://dx.doi.org/10.2165/00128413-199308770-00001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 505 (1994): 8. http://dx.doi.org/10.2165/00128415-199405050-00037.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

&NA;. "Interleukin 6." Reactions Weekly &NA;, no. 531 (1994): 8. http://dx.doi.org/10.2165/00128415-199405310-00027.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Song, Mingchen, and John A. Kellum. "Interleukin-6." Critical Care Medicine 33, Suppl (2005): S463—S465. http://dx.doi.org/10.1097/01.ccm.0000186784.62662.a1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

CASTELL, JOSé V., TILO ANDUS, DIETER KUNZ, and PETER C. HEINRICH. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 87–101. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24001.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

LEE, FRANK, CHOY-PIK CHIU, JANUSZ WIDEMAN, et al. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 215–29. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24015.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

CLARK, STEVEN C. "Interleukin-6." Annals of the New York Academy of Sciences 557, no. 1 (2008): 438–43. http://dx.doi.org/10.1111/j.1749-6632.1989.tb24036.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Interleukin-6"

1

Schebesta, Kathrin [Verfasser]. "Das Endothel sezerniert Interleukin-6 (IL-6) und stimuliert die adrenale Interleukin-6 und Aldosteronsynthese über einen Interleukin-6 unabhängigen Mechanismus / Kathrin Schebesta." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2015. http://d-nb.info/1079652612/34.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

OBAFEMI, TOLULOPE FESAYO. "THE EFFECTS OF INTERLEUKIN 6 AND INTERLEUKIN 10 ON FRAILTY IN C57BL/6 MICE." Thesis, The University of Arizona, 2016. http://hdl.handle.net/10150/613394.

Pełny tekst źródła
Streszczenie:
Studies have shown that pro-inflammatory IL-6 and anti-inflammatory IL-10 interleukins may correlate to frailty and aging. This frailty can be defined in the context of clinical symptoms which include sarcopenia and osteoporosis, decreased activity level; or in the context of increased susceptibility to adverse health outcomes from a deficient immune system. In this experiment we tested a cohort of conditionally regulated IL-6 and IL-10 mice with controls (IL-6tg+.rtTA(r/r) (n=8), IL-10(-/-). IL-10tg+ rtTA(r/r) (n=10) and rtTA(r/r) (n=5)) under frailty assessments and immunological cell analys
Style APA, Harvard, Vancouver, ISO itp.
3

Terry, Catherine. "Genetic control of Interleukin-6 gene." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.342452.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Höschen-Lihs, Jutta. "Interleukin-6- und Interleukin-2-Rezeptor als Aktivitätsmarker bei infektiöser Endokarditis." [S.l.] : [s.n.], 2005. http://archiv.ub.uni-marburg.de/diss/z2005/0327/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Siegmund, Annette. "Interleukin-11 - analog zu Interleukin-6 - ein direkter Modulator der Nebennierenrinde." Diss., lmu, 2008. http://nbn-resolving.de/urn:nbn:de:bvb:19-83542.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Desallais, Lucille. "Immunisation active à base de peptides, dérivés de l’IL-6 et de l’IL-1β, dans les maladies inflammatoires chroniques". Thesis, Paris, CNAM, 2013. http://www.theses.fr/2013CNAM0867.

Pełny tekst źródła
Streszczenie:
Les anticorps monoclonaux anti-cytokine ont constitué une révolution dans le traitement des maladies inflammatoires chroniques, mais leur utilisation présente des inconvénients (non réponse, résistance, effets secondaires, coûts élevés).Notre équipe développe une stratégie alternative originale, l’immunisation active à base de peptides de cytokines. Elle a pour but de faire synthétiser, par l’organisme même du patient, des anticorps neutralisant les effets pathogènes dus à l’excès de cytokines.Durant ma thèse, j’ai montré que l’immunisation active contre un peptide dérivé de l’IL-6 murine est
Style APA, Harvard, Vancouver, ISO itp.
7

Walter, Claudia. "Bestimmung der Zytokine Interleukin-1ra, Interleukin-6, Interleukin-10 und Interleukin-12 im Vaginalsekret bei Frauen mit Bakterieller Vaginose." Diss., lmu, 2004. http://nbn-resolving.de/urn:nbn:de:bvb:19-28461.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Slawik, Helen Christina. "Kontinuierliche Überexpression von Interleukin-6 im Zentralnervensystem lokale Applikation des Designerzytokins Hyper-Interleukin-6 im adulten Organismus der Ratte und Auswirkungen von exzitatorischen Neurotoxinen im Interleukin-6-transgenen Mausmodell /." [S.l.] : [s.n.], 2003. http://www.freidok.uni-freiburg.de/volltexte/842.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Gopinathan, Ganga. "The effects of interleukin-6 on angiogenesis." Thesis, Queen Mary, University of London, 2014. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8186.

Pełny tekst źródła
Streszczenie:
Elevated levels of the inflammatory cytokine interleukin-6, IL-6, have been linked with poor prognosis in ovarian cancer patients by influencing tumour growth, invasion, angiogenesis and chemo-resistance. A clinical trial conducted in parallel with pre-clinical studies showed an anti-IL-6 antibody to have some activity in ovarian cancer patients and in xenograft models, via reduction in pro-inflammatory and angiogenic factors such as TNF-α, IL-8 and VEGF. Anti-IL-6 treatment also showed significant reductions in vascular area with decreased expression of an angiogenic factor Jagged1. The aim o
Style APA, Harvard, Vancouver, ISO itp.
10

Sonnenberg, Sabine. "Tissue specific genetic regulation of Interleukin 6." Thesis, University of Southampton, 2009. https://eprints.soton.ac.uk/72590/.

Pełny tekst źródła
Streszczenie:
Interleukin 6 (IL6) is associated with arterial disease development, progression and surgical outcome. Raised levels of IL6 may play a causal role in disease development or may be the effect of pathology. An IL6 single nucleotide polymorphism (SNP) G- 174C has been identified and reported to associate with IL6 expression. However, conflicting results have emerged and both the relationship between IL6 and vascular disease and the precise effect of SNP G-174C in vivo in humans remains obscure. The aim of this study was to establish the effect of SNP G-174C in humans, in vivo in different tissues
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Interleukin-6"

1

Andrzej, Mackiewicz, Koj A, and Sehgal Pravinkumar B, eds. Interleukin-6-type cytokines. New York Academy of Sciences, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Tamas, Bartfai, and Ottoson David 1918-, eds. Neuro-immunology of fever. Pergamon Press, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Paulwitz, Adelheid. Diagnostische Wertigkeit von Interleukin-1, Interleukin-6, Interleukin-8, TNF-[alpha] [TNF-alpha] und PMN-Elastase bei akuter Pankreatitis. [s.n.], 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Young, Rosemary Irene. Cytokines and cancer: A focus on Interleukin-6. University of Manchester, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

B, Sehgal Pravinkumar, Grieninger Gerd, Tosato Giovanna, New York Academy of Sciences., and National Foundation for Cancer Research., eds. Regulation of the acute phase and immune responses: Interleukin-6. New York Academy of Sciences, 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Schwarze, Melinda Margarete K. Mechanisms of prevention of apoptosis in an interleukin-6-dependent myeloma cell line. National Library of Canada, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Moldoveanu, Andrei Ion. Effects of prolonged endurance exercise on the gene expression and plasma levels of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha. National Library of Canada, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Rindermann, Dominik. Serumbestimmung von TPS, [beta]2-Mikroglobulin, G-CSF und Interleukin-6 bei Patienten mit metastasierten Nierenzellkarzinom während überwiegend lokaler Immuntherapie mit Interleukin-2. [s.n.], 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Cournoyer, Micheline. Circulating endotoxin, interleukin-6 and tumor necrosis factor alpha in a porcine model of intraabdominal sepsis. National Library of Canada, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

1946-, Kluger Matthew J., Oppenheim Joost J. 1934-, and Powanda M. C, eds. The Physiologic, metabolic, and immunologic actions of interleukin-1: Proceedings of a symposium held in Ann Arbor, Michigan, June 4-6, 1985. Liss, 1985.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Interleukin-6"

1

Hirano, T., and T. Kishimoto. "Interleukin-6." In Peptide Growth Factors and Their Receptors I. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-49295-2_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Van Snick, J., and R. P. Nordan. "Interleukin 6." In Growth Factors, Differentiation Factors, and Cytokines. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74856-1_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chen, Taosheng. "Interleukin-6." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_3099-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Tanaka, Toshio, Masashi Narazaki, and Tadamitsu Kishimoto. "Interleukin-6." In Encyclopedia of Medical Immunology. Springer New York, 2014. http://dx.doi.org/10.1007/978-0-387-84828-0_38.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Gressner, A. M., and O. A. Gressner. "Interleukin-6." In Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1597-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Gressner, A. M., and O. A. Gressner. "Interleukin-6." In Springer Reference Medizin. Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1597.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Kishimoto, Tadamitsu, and Toshio Tanaka. "Interleukin 6." In Compendium of Inflammatory Diseases. Springer Basel, 2016. http://dx.doi.org/10.1007/978-3-7643-8550-7_179.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Hirano, T., and T. Kishimoto. "Interleukin-6." In Peptide Growth Factors and Their Receptors I. Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4612-3210-0_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Chen, Taosheng. "Interleukin-6." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_3099.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Chen, Taosheng. "Interleukin-6." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_3099.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Interleukin-6"

1

Morales, Jennifer M., Justin R. Bickford, Sanchao Liu, et al. "Photonic Integrated Circuits with Protein Catalyzed Capture Agents for Biosensing in Complex Media." In Optical Sensors. Optica Publishing Group, 2024. https://doi.org/10.1364/sensors.2024.stu1h.3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Hu, X., and R. Xing. "Effect of Alternating Electric Field on the Conformation and Function of Interleukin-6." In 2024 IEEE International Conference on Plasma Science (ICOPS). IEEE, 2024. http://dx.doi.org/10.1109/icops58192.2024.10626532.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jenkins, Brendan J., Louise McLeod, Alistair Miller, et al. "Interleukin-6 Promotes Emphysema By Apoptosis." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5800.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Gopinathan, Ganga, Carla Milagre, Oliver M. T. Pearce, et al. "Abstract 4162: Interleukin–6 stimulates defective angiogenesis." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4162.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Pereira da Silva, F., F. Luís, F. Jesus, et al. "Interleukin-6 in SARS-CoV2 risk stratification." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2216.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Perea, Beatrice, Miriana D’Alessandro, Laura Bergantini, et al. "Interleukin-6 and krebs von den lungen-6 in lymphangioleiomyomatosis patients." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa3949.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Wiegertjes, R., A. van Caam, H. van Beuningen, P. van der Kraan, F. van de Loo, and E. Blaney Davidson. "P078 Transforming growth factor-beta dampens pro-inflammatory interleukin-6 signaling in chondrocytes by decreasing the interleukin-6 receptor." In 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.67.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Tadjibayeva, K., and T. R. Romanovskaya. "REGULATORY ROLE OF INTERLEUKINS-4, 5 AND 6 IN THE DEVELOPMENT OF GLOMERULONEPHRITIS OF VARIOUS ETIOLOGIES." In SAKHAROV READINGS 2022: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2022. http://dx.doi.org/10.46646/sakh-2022-2-24-27.

Pełny tekst źródła
Streszczenie:
The relationship between the concentration of interleukin-4, 5, and 6 with the content of eosinophils and the level of C-reactive protein in patients with chronic glomerulonephritis was established. An increase in eosinophils was found in patients with chronic glomerulonephritis with a predominance of interleukin-4 compared with patients with a predominance of interleukin-5 and 6, which may be an important diagnostic marker of glomerulonephritis.
Style APA, Harvard, Vancouver, ISO itp.
9

Tsang, Andra, and Brian Oliver. "Budesonide reduced stone dust and cigarette smoke-induced interleukin 6 and interleukin 8 production." In ERS Congress 2024 abstracts. European Respiratory Society, 2024. http://dx.doi.org/10.1183/13993003.congress-2024.pa4894.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Kura, Yurie, Marco A. De Velasco, Yasuyuki Kobayashi, et al. "Abstract 1226: Interleukin-6 (IL-6) as a therapeutic target in prostate cancer." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-1226.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Interleukin-6"

1

Keller, Evan T. Interleukin-6 and Prostate Cancer Progression. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada398242.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Keller, Evan T. Interleukin-6 and Prostate Cancer Progression. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada407280.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Keller, Evan T. Interleukin-6 and Prostate Cancer Progression. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada418080.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Rokita, Hanna, Ruta Neta, and Jean D. Sipe. Increased Fibrinogen Synthesis in Mice During the Acute Phase Response: Co-Operative Interaction of Interleukin 1, Interleukin 6, and Interleukin 1 Receptor Antagonist. Defense Technical Information Center, 1993. http://dx.doi.org/10.21236/ada280464.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Knudsen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada435856.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Knudsen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada428439.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Knudesen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada416620.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Knudsen, Beatrice S. Hepatocyte Growth Factor and Interleukin-6 in Prostate Cancer Bone Metastasis. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada467982.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Huang, Xinyi, Manman Zhang, Jiaojiao Wang, and Fuyong Hu. Association between interleukin-6 levels and stroke:a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.5.0089.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

กาญจนทัต, อภิชาติ. ความเป็นพิษและการเหนี่ยวนำการตายแบบอะโพโทซิสต่อเซลล์มะเร็ง โดยเพปไทด์จากเกสรผึ้งพันธุ์ Apis mellifera. สถาบันวิจัยเทคโนโลยีชีวภาพและวิศวกรรมพันธุศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย, 2018. https://doi.org/10.58837/chula.res.2018.100.

Pełny tekst źródła
Streszczenie:
งานวิจัยนี้เตรียมโปรตีนไฮโดรไลเสตจากเกสรผึ้งพันธุ์ ที่ได้จากปฏิกิริยาย่อยสลายด้วยเอนไซม์ 3 ชนิด ได้แก่ แอลคาเลส ฟลาโวไซม์ และนิวเทรส พบว่าเมื่อใช้นิวเทรสในอัตราส่วนของเอนไซม์ต่อสับสเตรต 1:1 (NH1) โดยปริมาตร จะให้แสดงค่าการยับยั้งการสร้างอนุมูลอิสระด้วยวิธีไนตริกออกไซต์ได้ดีที่สุด คัดแยกเพปไทด์ที่มีขนาดโมเลกุลต่ำกว่า 0.65 กิโลดาลตัน (MW1) มีฤทธิ์ในการขจัดอนุมูลอิสระไนตริกออกไซด์ได้ดีที่สุด จากนั่นได้ทำการตรวจสอบความเป็นพิษของ MW1 ด้วยวิธี MTT และตรวจสอบ ผลการยับยั้งการสร้างไนตริกออกไซด์ในเซลล์แมคโครฟาจ RAW 264.7 ที่ถูกกระตุ้นด้วยไลโปโพลิแซคคาไรด์ พบว่า MW1 ไม่มีความเป็นพิษต่อเซลล์ และมีฤทธิ์ในก
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!